4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-20-000196
EVP Chief Commercial Officer sold 1,531 shares at an average $409.41 ($626,807)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DOUBLEDAY RICHARD EVP Chief Commercial Officer | 2020-06-23 | Sale | −355 | $407.13 | $144,531 | 5,767 | I |
| DOUBLEDAY RICHARD EVP Chief Commercial Officer | 2020-06-23 | Sale | −354 | $408.90 | $144,750 | 5,413 | I |
| DOUBLEDAY RICHARD EVP Chief Commercial Officer | 2020-06-23 | Sale | −595 | $410.26 | $244,107 | 4,818 | I |
| DOUBLEDAY RICHARD EVP Chief Commercial Officer | 2020-06-23 | Sale | −227 | $411.54 | $93,419 | 4,591 | I |
| Open-market sales · 1,531 sh · avg $409.41 · $626,807 | |||||||
Loading xslF345X03/edgardoc.xml…